Publications by authors named "R M Ridley"

Matrix stiffening by lysyl oxidase-like 2 (LOXL2)-mediated collagen cross-linking is proposed as a core feedforward mechanism that promotes fibrogenesis. Failure in clinical trials of simtuzumab (the humanized version of AB0023, a monoclonal antibody against human LOXL2) suggested that targeting LOXL2 may not have disease relevance; however, target engagement was not directly evaluated. We compare the spatial transcriptome of active human lung fibrogenesis sites with different human cell culture models to identify a disease-relevant model.

View Article and Find Full Text PDF

Electroactive organisms contribute to metal cycling, pollutant removal, and other redox-driven environmental processes. Studying this phenomenon in high-throughput is challenging since extracellular reduction cannot easily be traced back to its cell of origin within a mixed population. Here, we describe the development of a microdroplet emulsion system to enrich EET-capable organisms.

View Article and Find Full Text PDF

Despite increasing efforts across various disciplines, the fate, transport, and impact of synthetic plastics on the environment and public health remain poorly understood. To better elucidate the microbial ecology of plastic waste and its potential for biotransformation, we conducted a large-scale analysis of all publicly available meta-omic studies investigating plastics (n = 27) in the environment. Notably, we observed low prevalence of known plastic degraders throughout most environments, except for substantial enrichment in riverine systems.

View Article and Find Full Text PDF

The advanced form of AMD, geographic atrophy, is associated with increased RPE oxidative stress and chronic inflammation. Here we evaluated the effects of delivering an anti-inflammatory viral gene by an AAV-vector in a mouse model of geographic atrophy. We measured changes in retinal function, structure, and morphology over nine months with electroretinography, optical coherence tomography, and fundoscopy, respectively.

View Article and Find Full Text PDF
Article Synopsis
  • Cambodia is working towards eliminating malaria by 2025 but faces challenges with Plasmodium vivax (P.v) due to the high prevalence of G6PD deficiency, which complicates treatment options.
  • The study conducted in Pursat province involved creating and evaluating a new care pathway for treating P.v infections while considering G6PD status, using a collaborative approach with local stakeholders.
  • The new care pathway included point-of-care G6PD testing, referral systems, and community follow-up by Village Malaria Workers to enhance treatment adherence and improve health outcomes for patients.
View Article and Find Full Text PDF